Gala vs MangoRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent researchHow we rank →

MangoRx beats Gala overall, scoring 7.5/10 vs 7.2/10. Gala is more affordable at $149/mo vs $299/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose MangoRx for users who want a multi-service telehealth platform covering .

A side-by-side comparison of Gala and MangoRx covering pricing, scores, medication types, insurance, and more to help you decide.

Gala

#40 of 49
7.2/10

Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala
Higher Rated

MangoRx

#27 of 49
7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx
FeatureGalaMangoRx
Our Score7.2/107.5/10
Starting Price$149/mo$299/mo
Medication TypeBothCompounded
Insurance AcceptedNoNo
Best ForTirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress loggingUsers who want a multi-service telehealth platform covering weight loss and men's health
Ranking#40#27

Pros & Cons Compared

Gala

Pros

  • +Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
  • +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
  • +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
  • +All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

  • Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
  • Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
  • Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
  • Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
  • Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
  • Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

MangoRx

Pros

  • +Oral dissolving tablets exclusively — zero injections for any GLP-1 option
  • +Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
  • +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
  • +Free 100% online consultation with no video call required

Cons

  • $299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
  • Early-stage public company with limited revenue — stock performance reflects financial uncertainty
  • Only oral tablet format available — no injectable options if you want higher bioavailability

Our Verdict

MangoRx edges out Gala with a score of 7.5/10 vs 7.2/10. If budget is your priority, Gala starts at $149/mo compared to MangoRx's $299/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Gala nor MangoRx feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Gala

Starting at $149/mo

Visit Gala

Try MangoRx

Starting at $299/mo

Visit MangoRx

Related comparisons

Other matchups readers comparing Gala or MangoRx tend to look at next.

Top Picks

Four programs our readers click through most.

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Sesame Care

7.9/10
$99/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.